Hannah Went on the future of health diagnostics
Author: Michael
NKGen Biotech targets moderate-stage Alzheimers
Global experts and investors set to explore the
Haya Therapeutics, a Swiss‑US biotechnology com
VC releases in-depth analysis of leading compani
Healthspan Capital’s Sebastian Brunemeier on e
Epicore lands $26m to advance wearable sensors t
Immunomodulator demonstrates immune-mediated cle
Researchers warn that saliva and cheek swabs may
Fay and Berry Street demonstrate investor appeti